A prospective, randomised, open label study to compare the efficacy, safety and tolerability of 17B estradiol/TMG CC [estradiol/trimegestone] 1mg and tibolone in postmenopausal women.

Trial Profile

A prospective, randomised, open label study to compare the efficacy, safety and tolerability of 17B estradiol/TMG CC [estradiol/trimegestone] 1mg and tibolone in postmenopausal women.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2010

At a glance

  • Drugs Estradiol/trimegestone; Tibolone
  • Indications Menopausal syndrome
  • Focus Therapeutic Use
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 19 Nov 2010 Planned number of patients changed from 200 to 204.
    • 19 Nov 2010 Status changed from active, no longer recruiting to completed.
    • 14 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top